ELIQUIS

This brand name is authorized in Austria, Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug ELIQUIS contains one active pharmaceutical ingredient (API):

1 Apixaban UNII 3Z9Y7UWC1J - APIXABAN

Apixaban is a potent, oral, reversible, direct and highly selective active site inhibitor of factor Xa. It does not require antithrombin III for antithrombotic activity. Apixaban inhibits free and clot-bound factor Xa, and prothrombinase activity. By inhibiting factor Xa, apixaban prevents thrombin generation and thrombus development. Read about Apixaban

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ELIQUIS Film-coated tablet	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
B01AF02		B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AF Direct factor Xa inhibitors
Discover more medicines within B01AF02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10414D, 2735Y, 2744K, 5054B, 5061J, 5500L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 522720030084817, 522720030084917, 522720030085017, 522720030085117, 552817120062917
Country: CA	Health Products and Food Branch	Identifier(s): 02377233, 02397714
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): H4840513, H4850513
Country: EE	Ravimiamet	Identifier(s): 1531426, 1531437, 1531448, 1603729, 1603730, 1603741, 1603752, 1603763, 1603774, 1603785, 1603796, 1603808, 1658066, 1658088, 1790366
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 111691009, 111691010, 111691014, 11691002, 11691003, 11691005
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 071521, 186376, 375471, 426359, 445310
Country: FR	Base de données publique des médicaments	Identifier(s): 61902218, 69340279
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 195070, 195072, 195073, 216776, 296794, 367652, 367654, 374352, 374353, 374355, 374356, 379805, 379807, 381321, 381323, 381324
Country: HK	Department of Health Drug Office	Identifier(s): 61377, 62094
Country: IE	Health Products Regulatory Authority	Identifier(s): 14024, 14025, 14047, 31468, 31469, 36807, 36814, 36834
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 6941, 7157
Country: JP	医薬品医療機器総合機構	Identifier(s): 3339004F1029, 3339004F2025
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1060678, 1060679, 1060680, 1060681, 1060682, 1068553, 1068554, 1068555, 1068556, 1068557, 1068558, 1068559, 1068560, 1074840, 1074841
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 105678, 99066
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15592, 15593
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100245589, 100288512
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65619003, W65620009
Country: SG	Health Sciences Authority	Identifier(s): 14279P, 14407P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 15383011, 15383012, 1673041, 1673042, 1673043
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8681308010087, 8681308010094, 8681308095152, 8681308096166, 8681308098016, 8681308098023
Country: US	FDA, National Drug Code	Identifier(s): 0003-0893, 0003-0894, 55154-0612, 55154-0613, 63629-7747, 67296-1673, 70518-1861
Country: ZA	Health Products Regulatory Authority	Identifier(s): 47/8.2/0464